OPPICI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 2.212
EU - Europa 1.884
AS - Asia 1.644
SA - Sud America 205
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.989
Nazione #
US - Stati Uniti d'America 2.164
RU - Federazione Russa 789
CN - Cina 622
SG - Singapore 556
GB - Regno Unito 376
IT - Italia 184
BR - Brasile 166
VN - Vietnam 148
HK - Hong Kong 129
SE - Svezia 108
FR - Francia 85
DE - Germania 84
IE - Irlanda 78
FI - Finlandia 62
KR - Corea 50
IN - India 30
CA - Canada 26
BE - Belgio 22
JP - Giappone 22
UA - Ucraina 21
BD - Bangladesh 18
NL - Olanda 16
ID - Indonesia 15
ES - Italia 14
AR - Argentina 13
NG - Nigeria 13
IQ - Iraq 12
PL - Polonia 12
EC - Ecuador 9
TR - Turchia 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
AT - Austria 5
GR - Grecia 5
LT - Lituania 5
VE - Venezuela 5
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
UY - Uruguay 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LV - Lettonia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.989
Città #
Southend 313
Singapore 288
Moscow 254
Chandler 251
Dallas 246
Ashburn 225
San Jose 191
Woodbridge 138
Ann Arbor 132
Hong Kong 126
Beijing 122
Verona 110
Jacksonville 106
Dublin 78
The Dalles 59
Jinan 52
Council Bluffs 48
New York 47
Ho Chi Minh City 42
Houston 39
Nanjing 38
Los Angeles 34
Lawrence 33
Princeton 33
Shenyang 32
Hanoi 31
Hebei 30
Wilmington 29
Columbus 23
Tianjin 23
Haikou 21
São Paulo 21
Brussels 20
Seattle 20
Zhengzhou 20
Tokyo 19
Ningbo 18
Helsinki 17
Santa Clara 17
Buffalo 16
Changsha 16
Seoul 16
Munich 15
Montreal 14
Nanchang 14
Taizhou 14
Dong Ket 13
Hangzhou 13
Milan 13
Guangzhou 12
Lanzhou 12
Abuja 11
Jakarta 11
Redondo Beach 11
San Francisco 11
Stockholm 11
Belo Horizonte 10
Boardman 10
Chennai 10
Brooklyn 9
Fuzhou 9
Jiaxing 9
Taiyuan 9
Warsaw 8
Amsterdam 7
Da Nang 7
Denver 7
Kent 7
London 7
Norwalk 7
Orem 7
Phoenix 7
Frankfurt am Main 6
Johannesburg 6
Redwood City 6
Boston 5
Dearborn 5
Mumbai 5
Quito 5
Redmond 5
Athens 4
Atlanta 4
Biên Hòa 4
Cagliari 4
Falkenstein 4
Lancaster 4
Madrid 4
Perugia 4
Qingdao 4
Rio de Janeiro 4
Riva 4
Toronto 4
Auburn Hills 3
Baghdad 3
Caserta 3
Chicago 3
Detroit 3
Erbil 3
Falls Church 3
Fortaleza 3
Totale 3.814
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 303
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 262
Molecular and cellular insights into defects of human alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I 225
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 225
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 206
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 204
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 204
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 202
Folding defects leading to primary hyperoxaluria 201
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 199
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 195
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 194
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 192
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 190
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 186
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 181
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 178
Dimerization drives proper folding of human Alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 174
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia 173
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 171
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 168
Evolutionary divergent suppressor mutations in conformational diseases 167
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from Bacillus Subtilis at neutral pH 166
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 165
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 160
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 157
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 156
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 154
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 151
Molecular basis of primary hyperoxaluria: clues to innovative treatments 149
A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors 142
Molecular insights into primary hyperoxaluria Type I pathogenesis. 125
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 123
Totale 6.048
Categoria #
all - tutte 18.487
article - articoli 16.642
book - libri 0
conference - conferenze 701
curatela - curatele 0
other - altro 573
patent - brevetti 0
selected - selezionate 0
volume - volumi 571
Totale 36.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022339 28 142 28 9 7 3 6 20 16 8 12 60
2022/2023660 40 88 54 118 62 135 15 41 70 1 21 15
2023/2024262 16 13 11 15 30 50 5 35 5 15 48 19
2024/2025842 41 49 22 138 69 31 66 29 150 51 74 122
2025/20262.595 176 95 285 370 685 198 204 131 194 161 34 62
Totale 6.048